Effect of early chemoradiotherapy in patients with limited stage small cell lung cancer |
Ha, In-Bong
(Department of Radiation Oncology, Gyeongsang National University School of Medicine)
Jeong, Bae-Kwon (Department of Radiation Oncology, Gyeongsang National University School of Medicine) Jeong, Hojin (Department of Radiation Oncology, Gyeongsang National University School of Medicine) Choi, Hoon-Sik (Department of Radiation Oncology, Gyeongsang National University School of Medicine) Chai, Gyu-Young (Department of Radiation Oncology, Gyeongsang National University School of Medicine) Kang, Myoung-Hee (Institute of Health Science, Gyeongsang National University) Kim, Hoon Gu (Institute of Health Science, Gyeongsang National University) Lee, Gyeong-Won (Institute of Health Science, Gyeongsang National University) Na, Jae-Beom (Institute of Health Science, Gyeongsang National University) Kang, Ki-Mun (Department of Radiation Oncology, Gyeongsang National University School of Medicine) |
1 | van Loon J, De Ruysscher D, Wanders R, et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys 2010;77:329-36. DOI ScienceOn |
2 | Spiro SG, James LE, Rudd RM, et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 2006;24:3823-30. DOI ScienceOn |
3 | Tannock IF. Treatment of cancer with radiation and drugs. J Clin OncoI 1996;14:3156-74. DOI |
4 | Sohn HJ, Kim SW, Ahn JH, et al. Concurrent etoposide/cisplatin combination chemotherapy (EP) and thoracic radiotherapy after two cycles of EP for limited stage small cell lung cancer. Cancer Res Treat 2002;34:409-15. DOI |
5 | Kong FM, Lally BE, Chang JY, et al. ACR Appropriateness Criteria radiation therapy for small-cell lung cancer. Am J Clin OncoI 2013;36:206-13. DOI |
6 | Choi NC, Herndon JE 2nd, Rosenman J, et al. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twicedaily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 1998;16: 3528-36. DOI |
7 | Roof KS, Fidias P, Lynch TJ, Ancukiewicz M, Choi NC. Radiation dose escalation in limited-stage small-cell lung cancer. Int J Radiat Oncol Bioi Phys 2003;57:701-8. DOI ScienceOn |
8 | Bogart JA, Herndon JE 2nd, Lyss AP, et al. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808. Int J Radiat Oncol Bioi Phys 2004;59:460-8. DOI ScienceOn |
9 | Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-71. DOI ScienceOn |
10 | Yeo SG, Cho MJ, Kim SY, Kim KW, Kim JS. Twice daily radiation therapy plus concurrent chemotherapy for limited-stage small cell lung cancer. J Korean Soc Ther Radiol Oncol 2006;24:96-102. |
11 | Salama JK, Hodgson L, Pang H, et al. A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinumbased chemotherapy and 70 Gy daily radiotherapy: CALGB 30904. J Thorac Oncol 2013;8:1043-9. DOI |
12 | Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol 2004;22:3248-54. DOI ScienceOn |
13 | Su J, Zhu S, Liu Z, Jing S, Shen W, Li J. Prognostic analysis of limited-stage small cell lung cancer after chemoradiotherapy. Onkologie 2012;35:362-7. DOI ScienceOn |
14 | Fried DB, Morris DE, Poole C, et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol 2004;22:4837-45. DOI ScienceOn |
15 | Bonner JA, Sloan JA, Shanahan TG, et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol 1999;17:2681-91. DOI |
16 | Schild SE, Bonner JA, Shanahan TG, et al. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Int J Radiat Oncol Bioi Phys 2004;59:943-51. DOI ScienceOn |
17 | Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-44. DOI ScienceOn |
18 | Bunn PA Jr, Lichter AS, Makuch RW, et al. Chemotherapy alone or chemotherapy with chest radiation therapy in limited stage small cell lung cancer: a prospective, randomized trial. Ann Intern Med 1987;106:655-62. DOI ScienceOn |
19 | Perry MC, Eaton WL, Propert KJ, et al. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung. N Engl J Med 1987;316:912-8. DOI ScienceOn |
20 | Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 1992;327:1618-24. DOI ScienceOn |
21 | Warde P, Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 1992;10:890-5. DOI |
22 | De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J, Kester A, Rutten I, Lambin P. Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer. Ann Oncol 2006;17:543-52. DOI ScienceOn |
23 | Stinchcombe TE, Gore EM. Limited-stage small cell lung cancer: current chemoradiotherapy treatment paradigms. Oncologist 2010;15:187-95. DOI ScienceOn |
24 | Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study. J Clin Oncol 1997;15:893-900. |
25 | Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002;20:3054-60. DOI ScienceOn |
26 | Pujol JL, Carestia L, Daures JP. Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent. Br J Cancer 2000;83:8-15. DOI ScienceOn |
27 | Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993;11:336-44. |
28 | Sundstrom S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow up. J Clin Oncol 2002;20:4665-72. DOI ScienceOn |